Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Minocycline for Branch Retinal Vein Occlusion
NCT01468831Phase 2Completed
- Sponsor
- National Eye Institute
- Start
- Mar 2012
- Primary completion
- Feb 2020
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of minocycline in branch retinal vein occlusion (BRVO), sponsored by National Eye Institute. Started Mar 2012; status: completed.
02
Drugs
minocycline
03
Conditions
branch retinal vein occlusion (BRVO)
Beyond the preview
Go deeper on NCT01468831.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01468831.